Annual Pricing Review 2022-23

‹ PrevPage 1 of 4 · Source p. 11Next ›

NDIA Board Meeting - 28 November 2022 - 7. Corporate Plan Aspirations DOCUMENT 7 FOI 24/25-0638

OFFICIAL: SENSITIVE

NDIA Board meeting of 28 November 2022

The contents of this document are OFFICIAL: SENSITIVE

Agenda Item: 7.4.3

Agenda Item: Annual Pricing Review 2022-23

Paper Type: For Discussion

redacted: s22(1)(a)(ii) - irrelevant material

3.4. The most recent such exercise was the 2021-22 APR which took place over the 2021-22 financial year and was announced in June 2022 and implemented in July 2022. It incorporated extensive consultations and tailored pricing changes to disability supports which totalled 9%, comprising wage increases under the SCHADS award plus allowance for increases in compulsory superannuation and an additional 3.7%. No changes in prices were made for therapy supports, support coordination or plan management. redacted: s22(1)(a)(ii) - irrelevant material for capital items were increased with CPI.

OFFICIAL: SENSITIVE

Annual Price Review 7.4.3

Board deliberations relating to its statutory functions are confidential – see Board Resolution of 4 September 2017

Page 11 of 134 270

NDIA Board Meeting - 28 November 2022 - 7. Corporate Plan Aspirations

OFFICIAL: SENSITIVE

NDIA Board meeting of 28 November 2022

NDIS Review considerations

redacted: s22(1)(a)(ii) - irrelevant material

3.8. High recent rates of price inflation will increase expectation of an increase at or close to CPI inflation, especially for therapy providers whose prices have not increased since July 2019.

redacted: s22(1)(a)(ii) - irrelevant material

OFFICIAL: SENSITIVE

Annual Price Review 7.4.3

Board deliberations relating to its statutory functions are confidential – see Board Resolution of 4 September 2017

Page 12 of 134 271

NDIA Board Meeting - 28 November 2022 - 7. Corporate Plan Aspirations

OFFICIAL: SENSITIVE

NDIA Board meeting of 28 November 2022

redacted: s22(1)(a)(ii) - irrelevant material

4.3. No changes to prices for therapy supports, support coordination or plan management have been made for more than two years which presents increasing challenges in a high inflation environment.

4.4. In light of these contextual factors it is proposed that, the 2022-23 APR approach be limited in scope, whilst largely maintaining prices in real terms. An initial expectation for the 2022-23 APR, in line with the recommendation from the 2021-22 APR is that

redacted: s22(1)(a)(ii) - irrelevant material

4.4.4. Prices for other supports (primarily therapy and support coordination) be increased by 80% WPI/20% CPI.

redacted: s22(1)(a)(ii) - irrelevant material

OFFICIAL: SENSITIVE

Annual Price Review 7.4.3

Board deliberations relating to its statutory functions are confidential – see Board Resolution of 4 September 2017

Page 13 of 134 272

NDIA Board Meeting - 28 November 2022 - 7. Corporate Plan Aspirations

Attachment B – Issues of interests from ministerial correspondence and media

Ministerial correspondence/media issues of interests Details
Therapy supports Providers have expressed concerns that no price limit increase or inflation adjustment has been applied since July 2019. This implies a real reduction in support over the last three years.

redacted: s22(1)(a)(ii) - irrelevant material

1

Page 14 of 134 275